Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference44 articles.
1. Global trends in breast cancer incidence and mortality;Porter;Salud Publica Mex,2009
2. Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life;Gerber,2010
3. Mechanism-based target identification and drug discovery in cancer research;Gibbs;Science,2000
4. Cancer;Bradbury;Top Med Chem,2007
5. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation;Nakase;Int J Pharm,2008
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Artemether ameliorates acetaminophen-induced liver injury through Nrf2 pathway;Biomedicine & Pharmacotherapy;2024-10
2. The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT;Onco;2024-07-01
3. Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic;Pathology - Research and Practice;2024-02
4. Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer;Molecular Diversity;2024-01-16
5. Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer;British Journal of Cancer;2023-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3